Platelet-independent defect in hemostasis associated with sirolimus use

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 700-702

  Rampino, T ^a,b   Marasa M ^a   Malvezzi, P M ^a   Soccio, G ^a   Roscini, E ^a   Gamba, G ^a   Noris, P ^a   Alessiani, M ^a   Dal Canton, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ATENOLOL; ATORVASTATIN; BASILIXIMAB; COLLAGEN; CREATININE; CYCLOSPORIN; DIMER; DOXAZOSIN; ERYTHROPOIETIN; FIBRIN; FIBRINOGEN; HEMOGLOBIN; LACTATE DEHYDROGENASE; LEVOTHYROXINE; MYCOPHENOLIC ACID; RANITIDINE; RAPAMYCIN; RISTOCETIN; STEROID;

ADULT; ANOREXIA; ASTHENIA; BLEEDING TIME; BLOOD ANALYSIS; BLOOD CLOTTING; BODY TEMPERATURE; CASE REPORT; CELL CULTURE; CLINICAL FEATURE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DIURESIS; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG USE; DRUG WITHDRAWAL; FEMALE; FEVER; FIBRIN FORMATION; FIBRINOLYSIS; GENERAL CONDITION IMPROVEMENT; GRAFT REJECTION; HEMOSTASIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LABORATORY TEST; LEUKOCYTE; LIVER FUNCTION TEST; PHYSICAL EXAMINATION; PLATELET INDEPENDENT HEMOSTASIS DEFECT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; REMISSION; SIDE EFFECT; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

BLOOD PLATELETS; DRUG THERAPY, COMBINATION; FEMALE; HEMOSTASIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; SIROLIMUS;

EID: 2042515618     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.03.015     Document Type: Conference Paper

References (17)

1. Sehgal S.N. Sirolimus its discovery, biological properties, and mechanism of Action. Transplant Proc. 35:(Suppl 3A):2003;7S
2. Brown E.J., Alberts M.W., Shin T.B., et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 369:1994;756
3. Sabers C.J., Martin M.M., Brunn G.J., et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem. 270:1995;815
4. Sabatini D.M., Erdjument-Bromage H., Lui M., et al. RAFT1 a mammalian protein that binds to FKBP12 in a rapamycin dependent fashion and is homologous to yeast TORs. Cell. 78:1994;35
5. Jefferies H.B.J., Reinhard C., Kozma S.C., et al. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA. 91:1994;4441
6. Lai J.H., Tan T.H. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J Biol Chem. 269:1994;30077
7. Kreis H., et al. New strategies to reduce nephrotoxicity. Transplantation. 72:(Suppl):2001;99
8. Johnson R.W.G., Kreis H., Oberbauer R., et al. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation. 72:2001;777
9. Podbielski J., Schoenberg L. Use of sirolimus in kidney transplantation. Prog Transplant. 11:2001;29
10. Morice M.C., Serruys P., Sousa J., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773
11. Gallo R., Padurean A., Jayaraman T., et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 99:1999;2164
12. Sousa J.E., Costa M.A., Abizaid A., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. Circulation. 103:2001;192
13. Charpentier B., Groth C.G., Morales J.M., et al. Bicetre hospital experience with sirolimus-based therapy in human renal transplantation the Sirolimus European Renal Transplant Study. Transplantation Proc. 35:(Suppl 3A):2003;58S
14. Hong J.C., Kahan B.D. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients risk factors, incidence, progression, and management. Transplantation. 69:2000;2085
15. Meier-Kriesche H.U., Kaplan B. Toxicity and efficacy of sirolimus relationship to whole-blood concentration. Clin Ther. 22:(Suppl B):2000;B93
16. Kahan B.D., Napoli K.L., Kelly P.A., et al. Therapeutic drug monitoring of sirolimus correlation with efficacy and toxicity. Clin Transplant. 14:2000;97
17. Babinska A., Markell M.S., Salifu M.O., et al. Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant. 13:1998;3153